Skip to content

Biophy

3 viewers · 30d

Total raised

$6.6M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $6.6M
ROUNDS
1
INVESTORS
56
FOUNDED
N/A
HQ
Philadelphia, PA
SECTOR
AI
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

BioPhy, Inc. is a pioneering healthcare technology firm specializing in the application of artificial intelligence to transform drug development processes. By leveraging advanced AI solutions, the company aims to substantially reduce the inefficiencies and costs traditionally associated with bringing new pharmaceutical products to market.

What sets it apart

BioPhy stands out for its ability to predict clinical trial outcomes with over 80% accuracy, which significantly reduces both the time and resources spent on drug development.

Funding history

1 round
EquityMar 4, 2025
Form D
+$6.6M$6.6M total

Latest SEC filings

via EDGAR · CIK 0002062676
Form D · Mar 4, 2025View on EDGAR

Products

1 tracked

BioLogicAI

Predictive Analytics

BioLogicAI is an advanced predictive AI engine designed to analyze extensive clinical trial data, thereby forecasting study outcomes and optimizing decision-making in drug development. The platform evaluates the biological feasibility of prospective drug candidates and predicts their potential success in clinical trials.

  • Predictive analytics for clinical trial outcomes
  • Assessment of biological feasibility of drug candidates
  • Optimization of development decisions

Links

WebsiteSEC EDGAR filings